Browse by Series:

FDA Approval and 2 Priority Reviews in Bladder Cancer, and ASCO's Cancer Advance of the Year

Gina Columbus
Published Online: Thursday, Feb 09, 2017



Gina Columbus reports on an FDA approval and 2 priority reviews in bladder cancer, highlights from the 2017 European Cancer Congress, a European approval in lung cancer, and ASCO announces its Cancer Advance of the Year.
Slider Left
Slider Right


Gina Columbus reports on an FDA approval and 2 priority reviews in bladder cancer, highlights from the 2017 European Cancer Congress, a European approval in lung cancer, and ASCO announces its Cancer Advance of the Year.
View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Community Practice Connections™: Expert Perspectives in PARP Inhibition: Evolving Management Strategies in Ovarian CancerJun 24, 20172.0
Oncology Consultations®: Identifying Best Practices of the Multidisciplinary Team in CINV ManagementJun 28, 20172.0
Publication Bottom Border
Border Publication
$emailPop$